Valuation : Virbac

Market Cap 270.18Cr 313.19Cr 254.52Cr 231.9Cr 433.45Cr 30TCr 436.71Cr 3.01TCr 1.17TCr 15TCr 1.18TCr 1.15TCr 50TCr P/E 2026 *
15.8x
P/E 2027 * 14.3x
Enterprise Value 282.86Cr 327.88Cr 266.46Cr 242.78Cr 453.79Cr 31TCr 457.19Cr 3.15TCr 1.22TCr 16TCr 1.23TCr 1.2TCr 52TCr EV / Sales 2026 *
1.82x
EV / Sales 2027 * 1.69x
Free-Float
49.03%
Yield 2026 *
0.53%
Yield 2027 * 0.63%
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
-2.14%-.--% - - 313.19Cr
-1.41%+0.22%-50.68%-60.52% 3.15TCr
-2.23%-1.06%+39.65%+100.58% 1.23TCr
-3.69%-1.53%-15.90%+3.47% 383.1Cr
-1.09%-1.24%-1.69%+18.37% 313.19Cr
-3.60%-2.76%+46.90%+30.40% 199.62Cr
-0.72%-2.25%+14.91%+6.46% 190.33Cr
-4.13%+7.15%+1.98%+190.02% 162.08Cr
-3.25%+2.43%-20.28%-9.25% 120.53Cr
-1.46%-2.32%-10.95%-42.01% 102.56Cr
Average -2.38%-0.68%+0.44%+26.39% 650.22Cr
Weighted average by Cap. -1.93%-1.57%-18.50%-4.56%

Financials

2026 *2027 *
Net sales 155.09Cr 179.78Cr 146.1Cr 133.12Cr 248.81Cr 17TCr 250.68Cr 1.73TCr 671.29Cr 8.68TCr 675.08Cr 660.32Cr 29TCr 164.73Cr 190.95Cr 155.18Cr 141.39Cr 264.28Cr 18TCr 266.26Cr 1.84TCr 713Cr 9.22TCr 717.03Cr 701.35Cr 30TCr
Net income 17Cr 20Cr 16Cr 15Cr 27Cr 1.87TCr 28Cr 190.84Cr 74Cr 957.97Cr 74Cr 73Cr 3.15TCr 19Cr 22Cr 18Cr 16Cr 30Cr 2.08TCr 31Cr 211.39Cr 82Cr 1.06TCr 83Cr 81Cr 3.49TCr
Net Debt 13Cr 15Cr 12Cr 11Cr 20Cr 1.39TCr 20Cr 141.36Cr 55Cr 709.57Cr 55Cr 54Cr 2.33TCr 7.52Cr 8.71Cr 7.08Cr 6.45Cr 12Cr 822.99Cr 12Cr 84Cr 33Cr 420.77Cr 33Cr 32Cr 1.38TCr
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AA